Suppressor of Cytokine Signaling 1 (SOCS1)

Suppressor of Cytokine Signaling 1 (SOCS1) is a key negative regulator of cytokine signaling pathways, particularly the JAK/STAT pathway. It functions through a negative feedback loop, where its expression is induced by cytokines, and it subsequently inhibits further signaling. SOCS1 contains a Kinase Inhibitory Region (KIR) that directly inhibits JAK kinases, an SH2 domain for binding phosphorylated tyrosines, and a SOCS box that interacts with E3 ubiquitin ligases for proteasomal degradation of associated proteins. Aberrant SOCS1 expression, often through promoter hypermethylation, is implicated in various cancers and autoimmune diseases, highlighting its role in maintaining immune homeostasis and preventing excessive inflammation. Peptides derived from the KIR domain have shown anti-inflammatory effects in preclinical models.

Other names

SSI-1STAT-induced STAT inhibitor 1

KIR domain-derived peptides inhibit JAK kinase activity and downstream STAT-regulated inflammatory genes (e.g., CCL2, CCL5, TNFα).